The feel-good drink with Cannabis Extract

California Cannabis® is a pioneering functional drink. Not only does it contain the Nubrain® superb nootropic formula, but 10 mg of raw organic cannabis extract and the Neurocellin® patented plant stem cell technology. 

Cannabidiol, a cannabinoid or CBD is non-psychoactive, it does not have the intoxicating effects of THC. CBD can actually counteract the psychoactivity of THC and combat unpleasant effects of THC such as paranoia, anxiety, over-excitability, or memory-loss. CBD acts on completely different receptors and enzymes than THC. CBD is associated with a long list of health benefits and is considered the healing component of the cannabis plant.

​

With the Neurocellin® patented blend it helps increase alertness, provides sustained energy and over time maximizes the brain's potential.

​

Feel it working.

The feel good drink

Malibu Beach, California

​

Enjoy the moment

Ibiza, Spain

​

​

Anti-ageing

​

Sunset away

Scorpios, Mykonos Greece

​

​

Resources

​

​

1. Mathew RJ1, et al. Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. Psychiatry Res. (2002)

2. Ranganathan M1, et al. The effects of cannabinoids on serum cortisol and prolactin in humans. Psychopharmacology (Berl). (2009)

3. Balabanova S1, Parsche F, Pirsig W. First identification of drugs in Egyptian mummies. Naturwissenschaften. (1992)

4. Banerjee A1, et al. Effects of chronic bhang (cannabis) administration on the reproductive system of male mice. Birth Defects Res B Dev Reprod Toxicol. (2011)

5. Sharma P1, Murthy P, Bharath MM. Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iran J Psychiatry. (2012)

6. Ahmed SA1, et al. Cannabinoid ester constituents from high-potency Cannabis sativa. J Nat Prod. (2008)

7. Piluzza G, et al. Differentiation between fiber and drug types of hemp (Cannabis sativa L.) from a collection of wild and domesticated accessions. Genet Resour Crop Ev. (2013)

8. World Drug Report 2010.

9. Cinti S. Medical marijuana in HIV-positive patients: what do we know. J Int Assoc Physicians AIDS Care (Chic). (2009)

10. Seamon MJ. The legal status of medical marijuana. Ann Pharmacother. (2006)

11. Elsohly MA1, Slade D. Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. (2005)

12. Radwan MM1, et al. Isolation and characterization of new Cannabis constituents from a high potency variety. Planta Med. (2008)

13. Elsohly MA, El-Feraly FS, Turner CE. Isolation and characterization of (+)-cannabitriol and (-)-10-ethoxy-9-hydroxy-delta 6a{10a}-tetrahydrocannabinol: two new cannabinoids from Cannabis sativa L. extract. Lloydia. (1977)

14. Elsohly MA, Boeren EG, Turner CE. (+/-)9,10-Dihydroxy-delta6a(10a)-tetrahydrocannabinol and (+/-)8,9-dihydroxy-delta6a(10a)-tetrahydrocannabinol: 2 new cannabinoids from Cannabis sativa L. Experientia. (1978)

15. Grunfeld Y, Edery H. Psychopharmacological activity of some substances extracted from Cannabis sativa L (hashish). Electroencephalogr Clin Neurophysiol. (1969) A, et al. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int. (1995)

​​

​

​

​

​

​

​

​

​